AI-powered
patient
recruitment

We accelerate recruitment by enabling data-driven site selection.

contact us

Bringing down the cost of drug development

Site selection is the single most decisive step of a clinical trial. However, life science companies lack the tools to reliably screen sites & investigators at scale. As a consequence, in any given trial, 30% of sites do not recruit a single patient.

By accelerating clinical trials, Inato helps bring novel therapies to patients faster and at a more affordable price.